Patent: 7,635,570
✉ Email this page to a colleague
Summary for Patent: 7,635,570
Title: | Epidermal growth factor receptor gene copy number |
Abstract: | Methods of predicting whether an anti-epidermal growth factor receptor (\"EGFr\")-specific binding agent treatment will be efficacious in treating cancer, and methods of treating patients with anti-EGFr-specific binding agents, are provided. |
Inventor(s): | Siena; Salvatore (I-20146 Milan, IT), Moroni; Mauro (20126 Milan, IT), Bardelli; Alberto (I-10132 Turin, IT) |
Assignee: | |
Application Number: | 11/396,311 |
Patent Claims: | see list of patent claims |
Details for Patent 7,635,570
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Amgen, Inc. | VECTIBIX | panitumumab | Injection | 125147 | 09/27/2006 | ⤷ Try a Trial | 2025-04-01 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |